You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES TAKEDA<br />
Product Class Date Terms of Agreement<br />
Spectracef (cefditoren<br />
pivoxil)<br />
J 1997 TAP licensed-in exclusive rights to cefditoren pivoxil in<br />
North America from originator Meiji Seika. In 1999,<br />
Abbott obtained exclusive rights in Latin America, plus<br />
co-marketing rights in Europe (with Gruenenthal) and an<br />
option for the product in Asian countries outside Japan.<br />
However, Takeda and Abbott have now withdrawn from<br />
this deal.<br />
Benet (risedronic acid) M 1992 Originally developed by Procter & Gamble and licensed to<br />
Ajinomoto for Japan. It was then co-developed with<br />
sub-licensees Takeda and Aventis, following an<br />
agreement between P&G and Aventis to market the<br />
product worldwide.<br />
Basen (voglibose) A N/A Licensed out to Cheil for South Korea.<br />
Takepron (lansoprazole) A N/A Marketed by TAP jv with Abbott in the US, and by Takeda<br />
Pharma in German-speaking markets. Licensed out to<br />
Abbott for Canada and Latin America and to Boehringer<br />
Ingelheim and Roemmers for some Latin American<br />
countries. Almirall Prodesfarma for Spain. Wyeth for the<br />
UK, Denmark, Australia, Sweden, Norway and Pakistan.<br />
Aventis for France, Germany, the NL, Belgium, Africa and<br />
the Middle East. To Orion for Finland. To Han Il for South<br />
Korea.<br />
Blopress (candesartan<br />
cilexetil)/Blopress Comp<br />
(candesartan<br />
cilexetil/hydrochlorothiazi<br />
de)<br />
Uprima/Ixense (sublingual<br />
apomorphine)<br />
Adecut/Cupressin<br />
(delapril)<br />
C N/A Licensed out to AstraZeneca for exclusive marketing in<br />
Belgium, Denmark, Finland, the Netherlands, Norway,<br />
New Zealand, Australia, and South Africa, and<br />
co-marketing in the rest of the world outside Japan.<br />
Licensed out to Teva for Israel, Orion for Ireland, Almirall<br />
Prodesfarma for Spain, Abbott for co-marketing in<br />
Mexico, Brazil, and Argentina with AstraZeneca, and in<br />
Chile with Saval.<br />
G N/A Takeda has licensed-out the product to TAP for the USA.<br />
TAP has in turn licensed it out to Abbott for other<br />
markets. TAP holds exclusive worldwide rights to<br />
apomorphine for the treatment of Parkinson’s Disease.<br />
C N/A Licensed-out to Chiesi for Italy.<br />
Acel-Imune (DTP vaccine) J N/A Licensed out to Lederle-Praxis Biologicals (Wyeth) for<br />
markets outside Japan.<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 93